Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

Thu, 15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

----------

FTSE 100

----------

Credit Suisse cuts AstraZeneca to 'neutral' (outperform) - price target 11,000 pence

----------

Credit Suisse raises GSK to 'neutral' (underperform) - price target 1,430 (1,630) pence

----------

Jefferies cuts Hikma Pharmaceutical price target to 2020 (2290) pence - 'buy'

----------

Berenberg cuts Admiral Group price target to 2,819 (2,903) pence - 'buy'

----------

Berenberg raises InterContinental Hotels target to 6,500 (5,700) pence - 'buy'

----------

Barclays cuts Whitbread price target to 3,500 (4,000) pence - 'overweight'

----------

Berenberg cuts Howden Joinery group price target to 620 (780) pence - 'hold'

----------

RBC cuts Dechra Pharma price target to 4,000 (4,200) pence - 'outperform'

----------

HSBC raises BT Group to 'buy' (hold)

----------

FTSE 250

----------

JPMorgan raises Trainline price target to 425 (420) pence - 'neutral'

----------

Berenberg cuts Volution price target to 460 (550) pence - 'buy'

----------

Berenberg cuts Travis Perkins price target to 910 (1,000) pence - 'hold'

----------

Berenberg cuts Marshalls price target to 380 (400) pence - 'hold'

----------

Berenberg cuts Ibstock price target to 180 (210) pence - 'hold'

----------

Berenberg cuts Genuit price target to 470 (530) pence - 'buy'

----------

Berenberg starts Currys with 'hold' - price target 70 pence

----------

Barclays cuts John Wood Group price target to 250 (320) pence - 'overweight'

----------

Barclays cuts C&C Group price target to 230 (240) pence - 'overweight'

----------

Citigroup raises Tate & Lyle to 'buy' (neutral) - price target 850 pence

----------

Goldman Sachs cuts Marks & Spencer price target to 125 (140) pence - 'sell'

----------

Jefferies cuts Redrow price target to 768 (780) pence - 'buy'

----------

SMALL CAP

----------

Morgan Stanley raises AIB target to 3 (2,80) EUR - 'equal-weight'

----------

Morgan Stanley raises Bank of Ireland target to 7,60 (7,40) EUR - 'equal-weight'

----------

Jefferies cuts DFS Furniture price target to 210 (270) pence - 'buy'

----------

Berenberg cuts Eurocell price target to 250 (310) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 300 (310) pence - 'buy'

----------

Berenberg cuts Forterra price target to 250 (270) pence - 'hold'

----------

Berenberg cuts Breedon price target to 80 (100) pence - 'buy'

----------

Goldman Sachs cuts ITM Power price target to 120 (220) pence - 'sell'

----------

HSBC cuts Johnson Service Group to 'hold' (buy)

----------

Bank of America raises Fevertree Drinks price target to 1,030 (950) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
23 Feb 2022 09:37

LONDON BROKER RATINGS: SocGen cuts Kingfisher; Liberum raises Dechra

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
23 Feb 2022 07:59

Liberum upgrades Dechra after share price weakness

(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.

Read more
23 Feb 2022 07:59

Liberum upgrades Dechra after share price weakness

(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.

Read more
22 Feb 2022 19:07

easyJet could return to FTSE 100 next month, Dechra may be bumped

(Alliance News) - FTSE Russell late Tuesday indicated that, ahead of next week's quarterly UK index review, airline easyJet PLC could once again fly into the FTSE 100 index, with veterinary products company Dechra Pharmaceuticals PLC bumped out in the process.

Read more
22 Feb 2022 09:56

LONDON BROKER RATINGS: Jefferies downgrades three utility stocks

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
21 Feb 2022 12:14

LONDON MARKET MIDDAY: Stocks down as Russia pours cold water on summit

(Alliance News) - Stock prices in London turned lower at midday on Monday after conflicting statements about plans for a US-Russia summit to discuss Ukraine, dousing an earlier wave of optimism.

Read more
21 Feb 2022 09:11

TOP NEWS: Dechra Pharmaceuticals profit grows on more spending on pets

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher half-year profit and revenue amid increased consumer spending on pets.

Read more
21 Feb 2022 08:58

LONDON MARKET OPEN: Stocks rise on hope of US-Russia summit on Ukraine

(Alliance News) - Stock prices in London opened higher on Monday on hopes of a summit about Ukraine between US President Joe Biden and Russian President Vladimir Putin.

Read more
21 Feb 2022 08:04

Dechra Pharmaceuticals lifts interim dividend as profits rise

(Sharecast News) - Dechra Pharmaceuticals lifted its interim dividend on Monday as it posted a jump in profit and revenue.

Read more
21 Feb 2022 07:48

LONDON MARKET PRE-OPEN: Dechra raises dividend after strong results

(Alliance News) - Stock prices in London are seen opening higher on Monday on the possibility of a summit about Ukraine between US President Joe Biden and his Russian counterpart Vladimir Putin.

Read more
14 Feb 2022 16:43

UK earnings, trading statements calendar - next 7 days

<table style="width: 392px;" border="0" cellspacing="0" cellpadding="0"><colgroup><col width="271" /> <col width="121" /> </colgroup><tbody><tr><td class="xl68" width="271" height="21"><strong>Tuesday 15 February</strong></td><td class="xl67" width="121">&nbsp;</td></tr><tr><td class="xl67" height="21">BHP Group Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Glencore PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Plus500 Ltd</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">RM PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl69" height="21"><strong>Wednesday 16 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Coca-Cola Europacific Partners PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Indivior PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Ocean Outdoor Ltd</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">Pan African Resources PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Primary Health Properties PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl68" height="21"><strong>Thursday 17 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Aveva Group PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">MoneySupermarket.com PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Reckitt Benckiser Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Safestore Holdings PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">South32 Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Standard Chartered PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Yamana Gold Inc</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl68" height="21"><strong>Friday 18 February&nbsp;</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">NatWest Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Pod Point Group Holdings PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Segro PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">TBC Bank Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21"><strong>Monday 21 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Bank of Cyprus Holdings PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Dechra Pharmaceuticals PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Finsbury Food Group PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Sylvania Platinum Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Tristel PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">Wilmington PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">&nbsp;</td><td class="xl67">&nbsp;</td></tr><tr><td class="xl70" colspan="2" height="21">Copyright 2022 Alliance News Limited. All Rights Reserved.</td></tr></tbody></table>

Read more
13 Jan 2022 09:39

TOP NEWS: Dechra to post interim revenue growth, keeps annual outlook

TOP NEWS: Dechra to post interim revenue growth, keeps annual outlook

Read more
13 Jan 2022 09:11

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

Read more
13 Jan 2022 08:09

Dechra sees full year at upper end of management expectations

(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it reported a jump in first-half revenues.

Read more
11 Jan 2022 23:42

Dechra acquires worldwide rights to canine lymphoma treatment

(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine lymphoma from Anivive Lifesciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.